Discover the full management transaction log of Octopus Biosafety, a listed issuer based in France. Shares are listed on FR FR, under the oversight of AMF. Operating in the Healthcare & Pharma sector, Octopus Biosafety has logged 4 insider filings. Market capitalisation: €27.2m. The latest transaction was reported on 23 July 2024 — Acquisition. Among the most active insiders: Bertrand VERGNE. All data is accessible without an account.
FY ended December 2024 · cache
4 of 4 declarations
OCTOPUS BIOSAFETY is a French robotics company focused primarily on poultry farming applications. Its core value proposition is to provide autonomous, intelligent and modular robots designed to improve animal welfare, biosecurity, farm productivity and working conditions while reducing the burden of repetitive, low-value tasks. The company was founded in 1987 and has built a long track record in robotic systems for agricultural and service environments. It is listed on Euronext Access Paris under ISIN FR0013310281. The company’s product portfolio is centered on the XO robot, its flagship poultry solution. XO is designed to operate inside poultry houses, supporting litter management, flock stimulation and overall farm performance. OCTOPUS also markets T-Moov, stemming from the former TIBOT Technologies activity, as well as the Easy-LIT electric scarifier. Across these products, the strategic aim is consistent: automate recurring tasks, enhance hygiene and animal welfare, and deliver practical tools that help farmers improve technical and economic performance. A major step in the company’s development was the acquisition of TIBOT Technologies’ assets in 2022, which strengthened OCTOPUS BIOSAFETY’s expertise and broadened its installed base. More recently, the company has undergone significant corporate and financial restructuring. In July 2025, the Commercial Court of Lorient approved a restructuring plan, and the company subsequently announced a strategic alignment with The Autonomous Way (TAW), a U.S. group specialized in the robotization of facility management. Public disclosures indicate that OCTOPUS is now a subsidiary of TAW, suggesting industrial, technological and commercial synergies ahead. From a market standpoint, OCTOPUS BIOSAFETY is a niche player, but one with a differentiated technological profile in poultry robotics. Its solutions are positioned at the crossroads of agricultural automation and precision farming, with a clear emphasis on animal health, operational efficiency and data-driven management. The company has also been expanding its international footprint: XO was commercialized in France first and later abroad, and in 2025 OCTOPUS announced its first contract in Saudi Arabia with Tanmiah Food Company, one of the leading food groups in the region. Partnerships announced with EXCELCAR and the integration of industrial 5G into its robots further underline its ambition to industrialize and modernize its offering. Overall, OCTOPUS BIOSAFETY stands out as a specialized robotics company with strong expertise in animal-farming applications, an innovation-led product pipeline, and a strategy that increasingly combines agriculture, autonomous robotics and artificial intelligence. Its challenge is now to convert this technological differentiation into scalable commercial growth, both in France and in selected export markets.